Examining physical activity and sedentary behavior in adults with cystic fibrosis
Official title: Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
Run by Hospices Civils de Lyon · NCT06507956 · Data updated 2026-11-12
This study looks at how active or inactive adults with cystic fibrosis are to see how it affects their health and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 270 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Pierre-Bénite) |
| Status | Recruiting |
| Started | September 17, 2024 |
| Main results expected | September 3, 2026 |
| Study ends | March 3, 2027 |
| Registry record updated | November 21, 2025 |
| Trial ID | NCT06507956 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults with cystic fibrosis who are regularly monitored at Hôpital Lyon Sud.
✕Probably not a fit
Patients with significant co-morbidities that impair their ability to engage in physical activity or those whose clinical situation contraindicates exercise may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to characterize the physical activity and sedentary lifestyle profiles of adults diagnosed with cystic fibrosis. It focuses on understanding how these factors impact the health and quality of life of patients, especially in light of recent advancements in treatment options like CFTR modulators. By gathering data from patients regularly followed at Hôpital Lyon Sud, the study seeks to identify trends and potential areas for intervention to improve patient outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for adults with cystic fibrosis, enhancing their quality of life and health outcomes.
How similar studies have gone: While this study focuses on a specific population, similar studies have shown that understanding physical activity patterns can lead to meaningful improvements in chronic disease management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients (male or female) of legal age, * Patients with cystic fibrosis (CF) regularly followed at Hôpital Lyon Sud's cystic fibrosis center, who volunteered to take part in the study. Exclusion Criteria: * People who, due to the presence of co-morbidities, do not have motor and cognitive skills compatible with independent walking or orthostatic physical activity. * People whose clinical situation contraindicates the practice of adapted physical activity * Pregnant women * People who do not have the intellectual or linguistic capacity to understand the questionnaires * Persons deprived of their liberty by judicial or administrative decision * Persons under psychiatric care * Persons admitted to a health or social establishment for purposes other than research * Adults under legal protection (guardianship, curatorship). * Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
Where it's running
-
Hôpital Lyon Sud
Pierre-Bénite, France Recruiting
Study contacts
- Study coordinator: Raquel Sandra REIS DE CASTRO AZEVEDO
- Email: raquel-sandra.reis-de-castro-azevedo@chu-lyon.fr
- Phone: 00334 78 86 28 71
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inhaled CFTR mRNA for cystic fibrosis in Chinese patients aged 12 and older
This trial tests inhaled BMD003, a CFTR mRNA therapy, to see if it's safe and shows early signs of benefit in Chinese people 12 years and up with cystic fibrosis.
-
VX-272 dose escalation in healthy adults
This will test single and multiple increasing doses of the experimental drug VX-272 in healthy adults to see how safe it is and how the body handles it.
-
Prevalence of smoking, passive smoke exposure, and vaping among adults with cystic fibrosis
This project will see how common smoking, exposure to secondhand smoke, and vaping are among adults with cystic fibrosis followed at the Strasbourg Adult CF Center.
-
Dose escalation of VX-581 to check safety and drug levels in healthy adults
The trial will test increasing doses of VX-581 in healthy adults to see if it is safe and to measure how the body absorbs and clears the drug.
-
PALMIRE cohort: phenotyping inflammatory lung diseases to enable personalized care
This project will collect clinical, imaging, and biological data from adults with asthma, COPD, bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, or interstitial lung disease to try to identify disease subtypes and markers that could guide more personalized care.
-
Collecting sputum samples at home for cystic fibrosis patients
This study is testing if collecting sputum samples at home can help people with cystic fibrosis better identify lung infections compared to traditional methods done at the clinic.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.